The impact of the COVID-19 pandemic has been widespread, affecting the lives of every baby, child and young person in the country. This generation of children face unprecedented threats to their childhoods. They deserve an unprecedented response.
BACD and The Castang Foundation support UK research that includes children with neurodisability and their families, and are working together to invite research applications to improve the evidence around what treatments and interventions are effective, or not effective for children and families.
The Advisory Committee on Clinical Excellence Awards (ACCEA) has suspended applications for the 2020 national Clinical Excellence Awards competition – there is now no need to complete an application or for employers to sign-off those already submitted.
The UK and Ireland Upper Limb Rehabilitation Network has produced a consensus level guidance document to support the clinical reasoning and processes that accompany the administration of Botulinum Toxin Type A as an adjunct to evidence-based upper limb therapy in children and young people under 19 years of age.
The Castang Foundation is working in partnership with the National Institute for Health Research (NIHR) Academy to co-fund an NIHR-Castang Advanced Fellowship in 2019, which are designed for researchers at a postdoctoral level who:
The RCPCH and Newlife, a pioneering charity for children with disabilities, have combined forces to launch a new research fellowship for a post-doctoral researcher. The fellowship award will support the development of a talented individual to strengthen and deliver impactful childhood disability research and develop their own skills, knowledge and career. The award will see an investment of £263,000 to advance paediatric research in childhood disability.
The fellowship is open to any post-doctoral researcher (PhD or equivalent) who is a registered paediatrician to carry out childhood disabilities research in the UK.
Applications for the award are now live and close 09:00, Monday 4 November 2019.